Neurology Patient Monitoring Market Analysis report by Transparency Market Research shows that global sales in 2021 were held at US$ 4.2 Bn. With 7.6%, the projected market growth during 2022 - 2032 is expected to be significantly higher than the historical growth. Trauma is expected to be the highest revenue-generating application of the Neurology Patient Monitoring Market, with a CAGR of around 7.8% during 2022 – 2032.
As per the Neurology Patient Monitoring Industry research by Transparency Market Research - a market research and competitive intelligence provider, historically, from 2017 to 2021, market value of the Neurology Patient Monitoring increased at around 6.4% CAGR, wherein countries such as the U.S., UK, China, and Japan held a significant share in the global market.
Additionally, rising technical developments, growth in the prevalence of chronic diseases, the surge in the number of surgical procedures, and an uptick in the aging population are significant factors driving the growth. Owing to this, Neurology Patient Monitoring Market is projected to grow at a CAGR of 7.6% over the coming 10 years.
Increased occurrences of neurological illnesses, as well as an increase in the number of surgical procedures performed to address associated conditions, are propelling the neurology patient monitoring market forward. Furthermore, an increase in the number of vehicle accidents resulting in traumatic brain injuries is driving the need for neurology patient monitoring.
One of the primary factors driving the market for neurology patient monitoring is the increased occurrence of traumatic brain injuries caused by car accidents and sports injuries. According to the National Center for Biotechnology Information, roughly 1.7 million persons in the United States suffer with TBI each year, with 1.3 million of those patients ending up in an emergency room. As a result of these incidences, demand for neurology patient monitoring devices is likely to rise, boosting market growth throughout the forecast period.
Furthermore, an increase in the prevalence of hemorrhagic stroke among the elderly is expected to fuel market expansion during the forecast period. According to the World Health Organization, nearly 15 million people have a stroke every year, with 5 million deaths and another 5 million permanently disabled. Increased awareness initiatives, such as the WHO's Precious Time Campaign, which was started on World Stroke Day in 2021 to raise awareness of stroke, its symptoms, and how to get medical help. As a result, the need for proper diagnosis and treatment is influenced, resulting in market growth.
According to the Society of Vascular and Interventional Radiology, a stroke damages roughly 16 million people worldwide every year, killing around five million individuals, costing the U.S. Department for Health and Human Services around US$ 104 billion annually. Stroke is a time-sensitive ailment, so early care is crucial for a successful outcome. Medicine is extremely advanced with regard to intensive care unit procedures, but patients still have to wait, on average, ten hours for critical care. Nevertheless, exceptional casualties in patients who suffer strokes can contribute considerably to neurological patient monitoring in the coming decades.
Due to an increase in the senior population and the popularity of home care settings, vital sign monitor sales in Europe are predicted to expand. The need for neurological patient monitors in ICUS in this region is expected to rise as the need for critical care grows. The rising frequency of chronic diseases in South Asia and East Asia is further expected to increase demand for patient monitoring systems in these areas. The increased focus on healthcare infrastructure in nations such as China and India is expected to have a significant impact on the demand for multi-parameter patient monitoring systems.
The market for neurology patient monitoring in the U.S. is estimated at US$ 1.6 Bn in 2022 and is forecasted to grow at 7.5% CAGR during 2022 – 2032. Approximately 800,000 strokes occur in the United States each year, making them the leading cause of mortality in the country. Strokes are especially common among senior adults, with a stroke each decade significantly raising the risk of getting it. With these upscaling figures, the market for neurology patient monitoring in the country is expected to reach a valuation of US$ 3.3 Bn by 2032.
In the U.S., 10 seconds is the average length of exposure to the emergency room for someone suffering a headache. It is estimated that about 1.2 million people seek emergency care due to a headache each year. Increasing prevalence and relative improvement of neurology patient monitoring devices are expected to drive the market during the forecast period. For example, in May 2021, Neural Analytics unveiled its NovaGuide 2 and NovoSignal, which changed the time of diagnosis and therapy for concussions.
The U.K. was the second-largest market for neurology patient monitoring in 2021 with revenue standing at around US$ 152 Mn. Around 11 Mn people in the U.K. are living with a neurological condition. With these astounding figures, the market in the country is projected to reach a valuation of US$ 350 Mn by 2032, growing at a CAGR of 8% during 2022 – 2032.
The market for neurology patient monitoring in Japan is estimated at US$ 228 Mn. In 2018, of 523,283 cases around 34% cases pertained to the neurological sub-group. Considering the fact that the median age in Japan is high, neurological disorders are expected to remain a standing issue in the country. With these statistics, the neurological patient monitoring market in Japan is projected to reach a valuation of US$ 472 Mn by 2032.
South Korea reported a US$ 90 Mn market for Neurology patient monitoring. According to a study, recently, the prevalence of Neuromyelitis Optica Spectrum Disorder (NMOSD) in South Korea was 3.36 per 100,000 people. This is further expected to escalate in the forthcoming years. With these statistics, the market for neurology patient monitoring in South Korea is projected to reach a valuation of US$ 194 Mn by 2032.
In 2021, neurology patient monitoring revenue through trauma stood at US$ 1 Bn, accounting for nearly 24% of the revenue. According to a study, nearly 6 out of every 10 men and 5 out of every 10 women globally experience trauma at least once in their lifetime. In the U.S. itself, injury leads to more than 150,000 deaths and over 3 Mn non-fatal injuries every year. Injury leads to over 5 Mn deaths each year. A significant proportion of trauma leads to neurological disorders.
The key players in the neurology patient monitoring market are engaged in acquisitions and product launches. Some of the key companies operating in the neurology patient monitoring business include Medtronic, Integra LifeSciences, Raumedic AG, Sophysa, Spiegelberg GmbH, Natus Medical, Gaeltec Devices, and Neural Analytics.
Some of the key developments in the neurology patient monitoring business include:
Similarly, other recent developments in the neurology patient monitoring industry will be covered in the full report.
By Application
By Region
Attributes |
Details |
Global Neurology Patient Monitoring Market (2022) |
US$ 4.5 Bn |
Global Neurology Patient Monitoring Industry (2032) |
US$ 9.3 Bn |
Global Market CAGR (2022 – 2032) |
7.6% |
North America Market Share (2021) |
~40% |
U.S. Neurology Patient Monitoring Market CAGR (2022 – 2032) |
7.5% |
Key Companies Covered |
|
The Neurology Patient Monitoring Industry is worth more than US$ 4.5 Bn at present.
The value of the global Market is projected to increase at a CAGR of around 7.6% during 2022 – 2032.
The value of Neurology Patient Monitoring Market increased at a CAGR of around 6.4% during 2017– 2021.
Factors shaping the Neurology Patient Monitoring Market include the growing injuries and accidents leading to neurological disorders, which involves neurology patient monitoring.
The top 5 countries driving the market for neurology patient monitoring are US, the UK, China, Japan, and South Korea
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1.1. Producers
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
4. Global Neurology Patient Monitoring Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Neurology Patient Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Application
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032
5.3.1. Trauma
5.3.2. CSF Management
5.3.3. Migraine
5.3.4. Stroke
5.3.5. Hydrocephalus
5.3.6. EEG
5.3.7. Other Applications
5.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021
5.5. Absolute $ Opportunity Analysis By Application, 2022-2032
6. Global Neurology Patient Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Region
6.1. Introduction
6.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
6.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. East Asia
6.3.5. South Asia
6.3.6. Oceania
6.3.7. MEA
6.4. Market Attractiveness Analysis By Region
7. North America Neurology Patient Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country
7.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
7.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
7.2.1. By Country
7.2.1.1. U.S.
7.2.1.2. Canada
7.2.2. By Application
7.3. Market Attractiveness Analysis
7.3.1. By Country
7.3.2. By Application
7.4. Key Takeaways
8. Latin America Neurology Patient Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. Brazil
8.2.1.2. Mexico
8.2.1.3. Argentina
8.2.1.4. Rest of Latin America
8.2.2. By Application
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Application
8.4. Key Takeaways
9. Europe Neurology Patient Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Germany
9.2.1.2. Italy
9.2.1.3. France
9.2.1.4. U.K.
9.2.1.5. Spain
9.2.1.6. Russia
9.2.1.7. BENELUX
9.2.1.8. Rest of Europe
9.2.2. By Application
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Application
9.4. Key Takeaways
10. East Asia Neurology Patient Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. China
10.2.1.2. Japan
10.2.1.3. South Korea
10.2.2. By Application
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Application
10.4. Key Takeaways
11. South Asia Neurology Patient Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. India
11.2.1.2. Thailand
11.2.1.3. Malaysia
11.2.1.4. Indonesia
11.2.1.5. Rest of South Asia
11.2.2. By Application
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Application
11.4. Key Takeaways
12. Oceania Neurology Patient Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. Australia
12.2.1.2. New Zealand
12.2.2. By Application
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Application
12.4. Key Takeaways
13. MEA Neurology Patient Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. GCC
13.2.1.2. Rest of MEA
13.2.2. By Application
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Application
13.4. Key Takeaways
14. Key Countries Neurology Patient Monitoring Market Analysis
14.1. U.S.
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2021
14.1.2.1. By Application
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2021
14.2.2.1. By Application
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2021
14.3.2.1. By Application
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2021
14.4.2.1. By Application
14.5. Argentina
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2021
14.5.2.1. By Application
14.6. Germany
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2021
14.6.2.1. By Application
14.7. Italy
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2021
14.7.2.1. By Application
14.8. France
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2021
14.8.2.1. By Application
14.9. U.K.
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2021
14.9.2.1. By Application
14.10. Spain
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2021
14.10.2.1. By Application
14.11. Russia
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2021
14.11.2.1. By Application
14.12. BENELUX
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2021
14.12.2.1. By Application
14.13. China
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2021
14.13.2.1. By Application
14.14. Japan
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2021
14.14.2.1. By Application
14.15. South Korea
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2021
14.15.2.1. By Application
14.16. India
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2021
14.16.2.1. By Application
14.17. Thailand
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2021
14.17.2.1. By Application
14.18. Malaysia
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2021
14.18.2.1. By Application
14.19. Indonesia
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2021
14.19.2.1. By Application
14.20. Australia
14.20.1. Pricing Analysis
14.20.2. Market Share Analysis, 2021
14.20.2.1. By Application
14.21. New Zealand
14.21.1. Pricing Analysis
14.21.2. Market Share Analysis, 2021
14.21.2.1. By Application
14.22. GCC Countries
14.22.1. Pricing Analysis
14.22.2. Market Share Analysis, 2021
14.22.2.1. By Application
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Application
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Medtronic
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.1.5.2. Product Strategy
16.1.1.5.3. Channel Strategy
16.1.2. Integra LifeSciences
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.2.5.2. Product Strategy
16.1.2.5.3. Channel Strategy
16.1.3. Raumedic AG
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.3.5.2. Product Strategy
16.1.3.5.3. Channel Strategy
16.1.4. Sophysa
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.4.5.2. Product Strategy
16.1.4.5.3. Channel Strategy
16.1.5. Spiegelberg GmbH
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.5.5.2. Product Strategy
16.1.5.5.3. Channel Strategy
16.1.6. Natus Medical
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.6.5.2. Product Strategy
16.1.6.5.3. Channel Strategy
16.1.7. Gaeltec Devices
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.7.5.2. Product Strategy
16.1.7.5.3. Channel Strategy
16.1.8. Neural Analytics
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.8.5.2. Product Strategy
16.1.8.5.3. Channel Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
List of Tables
Table 1: Global Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 2: Global Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 3: North America Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 4: North America Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 5: Latin America Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 6: Latin America Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 7: Europe Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 8: Europe Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 9: East Asia Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 10: East Asia Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 11: South Asia Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 12: South Asia Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 13: Oceania Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 14: Oceania Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 15: MEA Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 16: MEA Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Application, 2017-2032
List of Figure
Figure 1: Global Neurology Patient Monitoring Market Value (US$ Mn) by Application, 2022-2032
Figure 2: Global Neurology Patient Monitoring Market Value (US$ Mn) by Region, 2022-2032
Figure 3: Global Neurology Patient Monitoring Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 4: Global Neurology Patient Monitoring Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 5: Global Neurology Patient Monitoring Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 6: Global Neurology Patient Monitoring Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 7: Global Neurology Patient Monitoring Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 8: Global Neurology Patient Monitoring Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 9: Global Neurology Patient Monitoring Market Attractiveness by Application, 2022-2032
Figure 10: Global Neurology Patient Monitoring Market Attractiveness by Region, 2022-2032
Figure 11: North America Neurology Patient Monitoring Market Value (US$ Mn) by Application, 2022-2032
Figure 12: North America Neurology Patient Monitoring Market Value (US$ Mn) by Country, 2022-2032
Figure 13: North America Neurology Patient Monitoring Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 14: North America Neurology Patient Monitoring Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 15: North America Neurology Patient Monitoring Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 16: North America Neurology Patient Monitoring Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 17: North America Neurology Patient Monitoring Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 18: North America Neurology Patient Monitoring Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 19: North America Neurology Patient Monitoring Market Attractiveness by Application, 2022-2032
Figure 20: North America Neurology Patient Monitoring Market Attractiveness by Country, 2022-2032
Figure 21: Latin America Neurology Patient Monitoring Market Value (US$ Mn) by Application, 2022-2032
Figure 22: Latin America Neurology Patient Monitoring Market Value (US$ Mn) by Country, 2022-2032
Figure 23: Latin America Neurology Patient Monitoring Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 24: Latin America Neurology Patient Monitoring Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 25: Latin America Neurology Patient Monitoring Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 26: Latin America Neurology Patient Monitoring Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 27: Latin America Neurology Patient Monitoring Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 28: Latin America Neurology Patient Monitoring Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 29: Latin America Neurology Patient Monitoring Market Attractiveness by Application, 2022-2032
Figure 30: Latin America Neurology Patient Monitoring Market Attractiveness by Country, 2022-2032
Figure 31: Europe Neurology Patient Monitoring Market Value (US$ Mn) by Application, 2022-2032
Figure 32: Europe Neurology Patient Monitoring Market Value (US$ Mn) by Country, 2022-2032
Figure 33: Europe Neurology Patient Monitoring Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 34: Europe Neurology Patient Monitoring Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 35: Europe Neurology Patient Monitoring Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 36: Europe Neurology Patient Monitoring Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 37: Europe Neurology Patient Monitoring Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 38: Europe Neurology Patient Monitoring Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 39: Europe Neurology Patient Monitoring Market Attractiveness by Application, 2022-2032
Figure 40: Europe Neurology Patient Monitoring Market Attractiveness by Country, 2022-2032
Figure 41: East Asia Neurology Patient Monitoring Market Value (US$ Mn) by Application, 2022-2032
Figure 42: East Asia Neurology Patient Monitoring Market Value (US$ Mn) by Country, 2022-2032
Figure 43: East Asia Neurology Patient Monitoring Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 44: East Asia Neurology Patient Monitoring Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 45: East Asia Neurology Patient Monitoring Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 46: East Asia Neurology Patient Monitoring Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 47: East Asia Neurology Patient Monitoring Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 48: East Asia Neurology Patient Monitoring Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 49: East Asia Neurology Patient Monitoring Market Attractiveness by Application, 2022-2032
Figure 50: East Asia Neurology Patient Monitoring Market Attractiveness by Country, 2022-2032
Figure 51: South Asia Neurology Patient Monitoring Market Value (US$ Mn) by Application, 2022-2032
Figure 52: South Asia Neurology Patient Monitoring Market Value (US$ Mn) by Country, 2022-2032
Figure 53: South Asia Neurology Patient Monitoring Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 54: South Asia Neurology Patient Monitoring Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 55: South Asia Neurology Patient Monitoring Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 56: South Asia Neurology Patient Monitoring Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 57: South Asia Neurology Patient Monitoring Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 58: South Asia Neurology Patient Monitoring Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 59: South Asia Neurology Patient Monitoring Market Attractiveness by Application, 2022-2032
Figure 60: South Asia Neurology Patient Monitoring Market Attractiveness by Country, 2022-2032
Figure 61: Oceania Neurology Patient Monitoring Market Value (US$ Mn) by Application, 2022-2032
Figure 62: Oceania Neurology Patient Monitoring Market Value (US$ Mn) by Country, 2022-2032
Figure 63: Oceania Neurology Patient Monitoring Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 64: Oceania Neurology Patient Monitoring Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 65: Oceania Neurology Patient Monitoring Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 66: Oceania Neurology Patient Monitoring Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 67: Oceania Neurology Patient Monitoring Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 68: Oceania Neurology Patient Monitoring Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 69: Oceania Neurology Patient Monitoring Market Attractiveness by Application, 2022-2032
Figure 70: Oceania Neurology Patient Monitoring Market Attractiveness by Country, 2022-2032
Figure 71: MEA Neurology Patient Monitoring Market Value (US$ Mn) by Application, 2022-2032
Figure 72: MEA Neurology Patient Monitoring Market Value (US$ Mn) by Country, 2022-2032
Figure 73: MEA Neurology Patient Monitoring Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 74: MEA Neurology Patient Monitoring Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 75: MEA Neurology Patient Monitoring Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 76: MEA Neurology Patient Monitoring Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 77: MEA Neurology Patient Monitoring Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 78: MEA Neurology Patient Monitoring Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 79: MEA Neurology Patient Monitoring Market Attractiveness by Application, 2022-2032
Figure 80: MEA Neurology Patient Monitoring Market Attractiveness by Country, 2022-2032